Global Pet CBD (cannabidiol) Market Research Report 2024

Publication ID:

PB506242919

Publication Date:

June 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Pet CBD (cannabidiol) market was valued at US$ 8 million in 2023 and is anticipated to reach US$ 10 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 401%.
This report aims to provide a comprehensive presentation of the global market for Pet CBD (cannabidiol), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet CBD (cannabidiol).
Report Scope
The Pet CBD (cannabidiol) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet CBD (cannabidiol) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet CBD (cannabidiol) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Canna-Pet
Choom Holdings
Receptra Naturals
Curaleaf
Trulieve Cannabis
Pure Spectrum
Cannabis Strategies Acquisition
Pet Releaf
Diamond CBD
PotNetwork Holdings
Kat's Naturals
Bluebird Botanicals
Segment by Type
CBD Capsule
CBD Oil
CBD Jelly
Other
Segment by Application
Pets Gastrointestinal Diseases
Pet Sleep Disorder
Pet Anxiety
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet CBD (cannabidiol) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet CBD (cannabidiol) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pet CBD (cannabidiol) Market Overview
1.1 Product Overview and Scope of Pet CBD (cannabidiol)
1.2 Pet CBD (cannabidiol) Segment by Type
1.2.1 Global Pet CBD (cannabidiol) Market Value Comparison by Type (2024-2030)
1.2.2 CBD Capsule
1.2.3 CBD Oil
1.2.4 CBD Jelly
1.2.5 Other
1.3 Pet CBD (cannabidiol) Segment by Application
1.3.1 Global Pet CBD (cannabidiol) Market Value by Application: (2024-2030)
1.3.2 Pets Gastrointestinal Diseases
1.3.3 Pet Sleep Disorder
1.3.4 Pet Anxiety
1.3.5 Other
1.4 Global Pet CBD (cannabidiol) Market Size Estimates and Forecasts
1.4.1 Global Pet CBD (cannabidiol) Revenue 2019-2030
1.4.2 Global Pet CBD (cannabidiol) Sales 2019-2030
1.4.3 Global Pet CBD (cannabidiol) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet CBD (cannabidiol) Market Competition by Manufacturers
2.1 Global Pet CBD (cannabidiol) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet CBD (cannabidiol) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet CBD (cannabidiol) Average Price by Manufacturers (2019-2024)
2.4 Global Pet CBD (cannabidiol) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet CBD (cannabidiol), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet CBD (cannabidiol), Product Type & Application
2.7 Pet CBD (cannabidiol) Market Competitive Situation and Trends
2.7.1 Pet CBD (cannabidiol) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet CBD (cannabidiol) Players Market Share by Revenue
2.7.3 Global Pet CBD (cannabidiol) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet CBD (cannabidiol) Retrospective Market Scenario by Region
3.1 Global Pet CBD (cannabidiol) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet CBD (cannabidiol) Global Pet CBD (cannabidiol) Sales by Region: 2019-2030
3.2.1 Global Pet CBD (cannabidiol) Sales by Region: 2019-2024
3.2.2 Global Pet CBD (cannabidiol) Sales by Region: 2025-2030
3.3 Global Pet CBD (cannabidiol) Global Pet CBD (cannabidiol) Revenue by Region: 2019-2030
3.3.1 Global Pet CBD (cannabidiol) Revenue by Region: 2019-2024
3.3.2 Global Pet CBD (cannabidiol) Revenue by Region: 2025-2030
3.4 North America Pet CBD (cannabidiol) Market Facts & Figures by Country
3.4.1 North America Pet CBD (cannabidiol) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet CBD (cannabidiol) Sales by Country (2019-2030)
3.4.3 North America Pet CBD (cannabidiol) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet CBD (cannabidiol) Market Facts & Figures by Country
3.5.1 Europe Pet CBD (cannabidiol) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet CBD (cannabidiol) Sales by Country (2019-2030)
3.5.3 Europe Pet CBD (cannabidiol) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet CBD (cannabidiol) Market Facts & Figures by Country
3.6.1 Asia Pacific Pet CBD (cannabidiol) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet CBD (cannabidiol) Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet CBD (cannabidiol) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet CBD (cannabidiol) Market Facts & Figures by Country
3.7.1 Latin America Pet CBD (cannabidiol) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet CBD (cannabidiol) Sales by Country (2019-2030)
3.7.3 Latin America Pet CBD (cannabidiol) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet CBD (cannabidiol) Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet CBD (cannabidiol) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet CBD (cannabidiol) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet CBD (cannabidiol) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet CBD (cannabidiol) Sales by Type (2019-2030)
4.1.1 Global Pet CBD (cannabidiol) Sales by Type (2019-2024)
4.1.2 Global Pet CBD (cannabidiol) Sales by Type (2025-2030)
4.1.3 Global Pet CBD (cannabidiol) Sales Market Share by Type (2019-2030)
4.2 Global Pet CBD (cannabidiol) Revenue by Type (2019-2030)
4.2.1 Global Pet CBD (cannabidiol) Revenue by Type (2019-2024)
4.2.2 Global Pet CBD (cannabidiol) Revenue by Type (2025-2030)
4.2.3 Global Pet CBD (cannabidiol) Revenue Market Share by Type (2019-2030)
4.3 Global Pet CBD (cannabidiol) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet CBD (cannabidiol) Sales by Application (2019-2030)
5.1.1 Global Pet CBD (cannabidiol) Sales by Application (2019-2024)
5.1.2 Global Pet CBD (cannabidiol) Sales by Application (2025-2030)
5.1.3 Global Pet CBD (cannabidiol) Sales Market Share by Application (2019-2030)
5.2 Global Pet CBD (cannabidiol) Revenue by Application (2019-2030)
5.2.1 Global Pet CBD (cannabidiol) Revenue by Application (2019-2024)
5.2.2 Global Pet CBD (cannabidiol) Revenue by Application (2025-2030)
5.2.3 Global Pet CBD (cannabidiol) Revenue Market Share by Application (2019-2030)
5.3 Global Pet CBD (cannabidiol) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Canna-Pet
6.1.1 Canna-Pet Corporation Information
6.1.2 Canna-Pet Description and Business Overview
6.1.3 Canna-Pet Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Canna-Pet Pet CBD (cannabidiol) Product Portfolio
6.1.5 Canna-Pet Recent Developments/Updates
6.2 Choom Holdings
6.2.1 Choom Holdings Corporation Information
6.2.2 Choom Holdings Description and Business Overview
6.2.3 Choom Holdings Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Choom Holdings Pet CBD (cannabidiol) Product Portfolio
6.2.5 Choom Holdings Recent Developments/Updates
6.3 Receptra Naturals
6.3.1 Receptra Naturals Corporation Information
6.3.2 Receptra Naturals Description and Business Overview
6.3.3 Receptra Naturals Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Receptra Naturals Pet CBD (cannabidiol) Product Portfolio
6.3.5 Receptra Naturals Recent Developments/Updates
6.4 Curaleaf
6.4.1 Curaleaf Corporation Information
6.4.2 Curaleaf Description and Business Overview
6.4.3 Curaleaf Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Curaleaf Pet CBD (cannabidiol) Product Portfolio
6.4.5 Curaleaf Recent Developments/Updates
6.5 Trulieve Cannabis
6.5.1 Trulieve Cannabis Corporation Information
6.5.2 Trulieve Cannabis Description and Business Overview
6.5.3 Trulieve Cannabis Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Trulieve Cannabis Pet CBD (cannabidiol) Product Portfolio
6.5.5 Trulieve Cannabis Recent Developments/Updates
6.6 Pure Spectrum
6.6.1 Pure Spectrum Corporation Information
6.6.2 Pure Spectrum Description and Business Overview
6.6.3 Pure Spectrum Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pure Spectrum Pet CBD (cannabidiol) Product Portfolio
6.6.5 Pure Spectrum Recent Developments/Updates
6.7 Cannabis Strategies Acquisition
6.6.1 Cannabis Strategies Acquisition Corporation Information
6.6.2 Cannabis Strategies Acquisition Description and Business Overview
6.6.3 Cannabis Strategies Acquisition Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cannabis Strategies Acquisition Pet CBD (cannabidiol) Product Portfolio
6.7.5 Cannabis Strategies Acquisition Recent Developments/Updates
6.8 Pet Releaf
6.8.1 Pet Releaf Corporation Information
6.8.2 Pet Releaf Description and Business Overview
6.8.3 Pet Releaf Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pet Releaf Pet CBD (cannabidiol) Product Portfolio
6.8.5 Pet Releaf Recent Developments/Updates
6.9 Diamond CBD
6.9.1 Diamond CBD Corporation Information
6.9.2 Diamond CBD Description and Business Overview
6.9.3 Diamond CBD Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Diamond CBD Pet CBD (cannabidiol) Product Portfolio
6.9.5 Diamond CBD Recent Developments/Updates
6.10 PotNetwork Holdings
6.10.1 PotNetwork Holdings Corporation Information
6.10.2 PotNetwork Holdings Description and Business Overview
6.10.3 PotNetwork Holdings Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PotNetwork Holdings Pet CBD (cannabidiol) Product Portfolio
6.10.5 PotNetwork Holdings Recent Developments/Updates
6.11 Kat's Naturals
6.11.1 Kat's Naturals Corporation Information
6.11.2 Kat's Naturals Pet CBD (cannabidiol) Description and Business Overview
6.11.3 Kat's Naturals Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kat's Naturals Pet CBD (cannabidiol) Product Portfolio
6.11.5 Kat's Naturals Recent Developments/Updates
6.12 Bluebird Botanicals
6.12.1 Bluebird Botanicals Corporation Information
6.12.2 Bluebird Botanicals Pet CBD (cannabidiol) Description and Business Overview
6.12.3 Bluebird Botanicals Pet CBD (cannabidiol) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bluebird Botanicals Pet CBD (cannabidiol) Product Portfolio
6.12.5 Bluebird Botanicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet CBD (cannabidiol) Industry Chain Analysis
7.2 Pet CBD (cannabidiol) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet CBD (cannabidiol) Production Mode & Process
7.4 Pet CBD (cannabidiol) Sales and Marketing
7.4.1 Pet CBD (cannabidiol) Sales Channels
7.4.2 Pet CBD (cannabidiol) Distributors
7.5 Pet CBD (cannabidiol) Customers
8 Pet CBD (cannabidiol) Market Dynamics
8.1 Pet CBD (cannabidiol) Industry Trends
8.2 Pet CBD (cannabidiol) Market Drivers
8.3 Pet CBD (cannabidiol) Market Challenges
8.4 Pet CBD (cannabidiol) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Canna-Pet
Choom Holdings
Receptra Naturals
Curaleaf
Trulieve Cannabis
Pure Spectrum
Cannabis Strategies Acquisition
Pet Releaf
Diamond CBD
PotNetwork Holdings
Kat's Naturals
Bluebird Botanicals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂